Chip Baird
Chief Executive Officer at 2SEVENTY BIO, INC.
Net worth: 1 M $ as of 29/04/2024
Chip Baird active positions
Companies | Position | Start | End |
---|---|---|---|
2SEVENTY BIO, INC. | Director/Board Member | - | - |
Chief Executive Officer | - | - | |
Comptroller/Controller/Auditor | - | - | |
Chief Operating Officer | 09/09/2023 | - | |
Director of Finance/CFO | - | - | |
President | 28/01/2024 | - | |
Deep Genomics, Inc.
Deep Genomics, Inc. BiotechnologyHealth Technology Deep Genomics, Inc. provides machine learning, genome biology and precision medicine. It develops an integrated computational system that could learn, predict, and interpret how genetic variation, whether natural or therapeutic, alters crucial cellular processes. The firm offers SPIDEX database, which is a set of genetic variants and their predicted effects on human splicing across the entire genome. Its SPIDEX database covers all synonymous, missense, and nonsense exonic SNVs, as well as intronic SNVs that are up to 300nt from splice junctions. The company was founded by Brendan Frey and Hui Yuan Xiong in 2015 and is headquartered in Toronto, Canada. | Independent Dir/Board Member | 05/01/2023 | - |
Chairman | 14/09/2023 | - | |
Director/Board Member | 05/01/2023 | 14/09/2023 |
Career history of Chip Baird
Former positions of Chip Baird
Companies | Position | Start | End |
---|---|---|---|
AXCA HEALPAR | Director/Board Member | 26/06/2018 | 31/10/2023 |
Independent Dir/Board Member | 26/06/2018 | 31/10/2023 | |
BLUEBIRD BIO, INC. | Comptroller/Controller/Auditor | 18/02/2021 | 03/11/2021 |
Director of Finance/CFO | 10/02/2019 | 03/11/2021 | |
AMICUS THERAPEUTICS, INC. | Director of Finance/CFO | 15/04/2012 | 18/12/2018 |
PTC THERAPEUTICS, INC. | Director of Finance/CFO | 31/12/2001 | 31/03/2012 |
The Lek/Alcar Consulting Group, Inc.
The Lek/Alcar Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Lek/Alcar Consulting Group, Inc. provides business strategy consulting services. It offers strategy, finance, marketing and sales, operations, and transaction services including business unit strategy, brand management, pricing, alliances and joint ventures, product development, corporate transformation, and operations design. It serves the defense, energy, health, building and construction, aerospace, media, retail, and telecommunications industries. The company was founded by Andrew Kutter in 1983 and is headquartered in Boston, MA. | Corporate Officer/Principal | 31/07/1999 | 31/12/2001 |
Amicus Therapeutics UK Ltd.
Amicus Therapeutics UK Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Amicus Therapeutics, Inc., Amicus Therapeutics UK Ltd. is a company that focuses on delivering high-quality therapies for persons living with rare and orphan diseases. The company is based in Gerrards Cross, UK. The employees of Amicus crafted a belief statement that encompasses their core values and reminds them of the reason they do what they do every day. The statement outlines the fundamental beliefs that are crucial to understanding the passion and commitment behind Amicus. The British company believes in the fight to remain at the forefront of therapies for rare and orphan diseases, supporting the disease communities and their families, and fostering teamwork and respect for each individual's contribution. | Director/Board Member | 15/04/2012 | - |
Training of Chip Baird
Edmund A. Walsh School of Foreign Service | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Statistics
International
United States | 9 |
United Kingdom | 2 |
Canada | 2 |
Operational
Director of Finance/CFO | 4 |
Director/Board Member | 4 |
Independent Dir/Board Member | 2 |
Sectoral
Health Technology | 7 |
Commercial Services | 3 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 5 |
---|---|
PTC THERAPEUTICS, INC. | Health Technology |
AMICUS THERAPEUTICS, INC. | Health Technology |
AXCA HEALPAR | Health Technology |
BLUEBIRD BIO, INC. | Health Technology |
2SEVENTY BIO, INC. | Health Technology |
Private companies | 3 |
---|---|
The Lek/Alcar Consulting Group, Inc.
The Lek/Alcar Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Lek/Alcar Consulting Group, Inc. provides business strategy consulting services. It offers strategy, finance, marketing and sales, operations, and transaction services including business unit strategy, brand management, pricing, alliances and joint ventures, product development, corporate transformation, and operations design. It serves the defense, energy, health, building and construction, aerospace, media, retail, and telecommunications industries. The company was founded by Andrew Kutter in 1983 and is headquartered in Boston, MA. | Commercial Services |
Amicus Therapeutics UK Ltd.
Amicus Therapeutics UK Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Amicus Therapeutics, Inc., Amicus Therapeutics UK Ltd. is a company that focuses on delivering high-quality therapies for persons living with rare and orphan diseases. The company is based in Gerrards Cross, UK. The employees of Amicus crafted a belief statement that encompasses their core values and reminds them of the reason they do what they do every day. The statement outlines the fundamental beliefs that are crucial to understanding the passion and commitment behind Amicus. The British company believes in the fight to remain at the forefront of therapies for rare and orphan diseases, supporting the disease communities and their families, and fostering teamwork and respect for each individual's contribution. | Commercial Services |
Deep Genomics, Inc.
Deep Genomics, Inc. BiotechnologyHealth Technology Deep Genomics, Inc. provides machine learning, genome biology and precision medicine. It develops an integrated computational system that could learn, predict, and interpret how genetic variation, whether natural or therapeutic, alters crucial cellular processes. The firm offers SPIDEX database, which is a set of genetic variants and their predicted effects on human splicing across the entire genome. Its SPIDEX database covers all synonymous, missense, and nonsense exonic SNVs, as well as intronic SNVs that are up to 300nt from splice junctions. The company was founded by Brendan Frey and Hui Yuan Xiong in 2015 and is headquartered in Toronto, Canada. | Health Technology |
- Stock Market
- Insiders
- Chip Baird
- Experience